INSIGHTS ON DRUG DEVELOPMENT

• Optimize Your RNA-LNP Delivery With Ionizable Lipids

  Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.

• Getting The Most Out Of Cell-Based Assays With The Optimal Read Function

  Gain insight into a whole-well fluorescence analysis that improves sensitivity and reproducibility in cell-based assays by accounting for uneven cell distribution.

• Development Of A Non-Standard Protein Therapeutic

  Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.

• Drug Substance For Early Clinical Phase Initiation

  Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.

• Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency

  9/25/2025

  Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

• Solubility And Improved Patient Outcomes

  9/9/2026

  Poor solubility poses major development challenges. Innovative formulation technologies and careful excipient selection can improve bioavailability and product performance.

• White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges

  10/16/2024

  Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.

• Exosome Production From hMSC Using A Fixed-Bed Bioreactor

  11/3/2025

  Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

• A CDMO Is The Nexus Between Green Chemistry And Commercialization

  2/24/2026

  Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.